Judit Börcsök Pilmark

ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer

Zhou, Y., Börcsök, J., Adib, E., Kamran, S. C., Neil, A. J., Stawiski, K., Freeman, D., Stormoen, D. R., Sztupinszki, Z., Samant, A., Nassar, A., Bekele, R. T., Hanlon, T., Valentine, H., Epstein, I., Sharma, B., Felt, K., Abbosh, P., Wu, C. L., Efstathiou, J. A. & 4 others, Miyamoto, D. T., Anderson, W., Szallasi, Z. & Mouw, K. W., 2023, In: Science Advances. 9, 47, 16 p., eadg2263.

Research output: Contribution to journal › Journal article › Research › peer-review

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Prosz, A., Duan, H., Tisza, V., Sahgal, P., Topka, S., Klus, G. T., Börcsök, J., Sztupinszki, Z., Hanlon, T., Diossy, M., Vizkeleti, L., Stormoen, D. R., Csabai, I., Pappot, H., Vijai, J., Offit, K., Ried, T., Sethi, N., Mouw, K. W., Spisak, S. & 2 others, Pathania, S. & Szallasi, Z., 2023, In: Scientific Reports. 13, 10 p., 20567.

Research output: Contribution to journal › Journal article › Research › peer-review